Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | General Pharmaceutical Council |
| Main Category: | Services |
| Procurement Method: | Open procedure |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): |
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
14 November 2024
Closed
Estimated Value
£79,354.28
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| £79,354.28 |
| Release Date: | 10 January 2025 |
| Application Deadline: | 14 November 2024 |
| Contract Start Date: | 1 January 2025 |
| Contract End Date: | 31 December 2026 |
| Contract Duration: | 2.0 years |
| Procurement ID (OCID): | ocds-b5fd17-f1baf2fd-e312-4f71-b8c8-551496f72a65 |
| Notice Reference: | 3547a74b-803e-48ec-bf1e-51182d1e66c8-816395 |
View Original Notice
Access the full notice on the official portal
Awarded to
| Award value: | £79,354.28 |
| Award decision date: | 14 November 2024 |
| Award status: | Active |
GPhC are seeking to procure health and safety consultancy to provide support for our Facilities team and services to all employees particularly the inspectors team during their working onsite. Additional information: The contracting authority considers that this contract may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.
Published contracts in the last 12 months
19
total contracts
£5.6m
total value
£560,974
average contract size
Typical categories
Examinations Marking and Psychometric Data Analysis Services
General Pharmaceutical Council · WAC-594514
Examinations Marking and Psychometric Data Analysis Services
General Pharmaceutical Council · WAC-594531
Salary benchmarking and Rewards Advisory Services
General Pharmaceutical Council · WAC-485794